Newsroom

New Blood Testing Technology May Be Effective in Detecting Mutations

A new blood testing technology may lead to major changes in treatment of Gastrointestinal Stromal Tumors. In a study presented in April by Dr. George Demetri of the Dana-Farber Cancer Institute at the American Association for Cancer Research annual meeting, the blood test was shown to be more effective than traditional biopsies in identifying secondary mutations in GIST.

By |2019-04-08T08:57:19-04:00June 11th, 2013|Mutational Testing, Mutations, News|

Carrie Broussard and Her ‘Little Brave Warrior’

Carrie Broussard gave birth to a healthy baby boy on May 1, after finding out she was pregnant in the midst of treatment with Gleevec. She named him Caelum, which in the Celtic origin means ‘brave warrior’ and in the Australian origin means ‘a gift.”

By |2018-07-06T13:41:08-04:00June 11th, 2013|Gleevec, Member Stories, News|

GIST patient shares her experience with Hospital

LRG Global Relations Coordinator Piga Fernández Kaempffer, a GIST patient, gave a conference about her own disease, drawing the attention of professionals, who carefully listened as she shared with them from her perspective the evolution of this pathology.

By |2019-09-20T12:35:20-04:00June 11th, 2013|Advocacy, Global, Member Stories, News|

Rodrigo Salas encourages universities to discuss GIST and other rare diseases

Rodrigo Salas, the President of Fundación GIST México, participated in the XVL Ordinary Session of the Mexican Academy of Faculties of Medicine on April 19

By |2019-09-20T12:35:50-04:00June 11th, 2013|Advocacy, Global, News|

Breaking Research Barriers – Our Unique Team Searches for a Cure

Breaking Research Barriers! The Life Raft Group Research Team is unique. As we know, the purpose of research is to inform, educate and allow us to live better lives.

By |2018-08-01T14:32:17-04:00June 4th, 2013|Fundraising, News, Research, Video|
Go to Top